ResourcesFor Physicians
Learn▾
Still Losing Vision?Why Vision Keeps Declining?Does Acupuncture Work?TCM & Ayurveda for Eye DiseaseInherited Retinal DiseaseScientific Studies & ResearchContributing to Our Research
About▾
About Netra Eye InstituteMeet the TeamLocationsNews
FAQBlogContact Us
Request Consultation
Netra Eye Institute clinic exterior banner for physicians

For Physicians

How we partner with ophthalmologists and optometrists on integrative eye care.

A Collaborative, Science-Informed Approach to Complex Ophthalmic Disease

Netra Eye Institute is a specialty center dedicated to the integrative eyecare management of chronic, progressive, and refractory ocular conditions. We collaborate with ophthalmologists, optometrists, and other healthcare professionals who seek adjunctive therapeutic strategies for patients whose disease course may not be fully addressed by conventional interventions alone.

Our clinical model emphasizes co-management, transparent communication, and biologically plausible therapeutic mechanisms that align with contemporary research in ocular blood flow regulation, neuroprotection, inflammation control, and retinal metabolic support.

Download Netra Restoration Therapy Booklet

Netra Restoration Therapy full-spectrum brochure

Full-Spectrum Complementary Eye Care

Delivering full-spectrum integrative eye care that complements conventional ophthalmology by addressing the underlying cellular, metabolic, vascular, inflammatory, and neurodegenerative contributors to visual dysfunction and disease progression.

BUILT ON HOLISTIC, FULL-SPECTRUM TREATMENTS SUPPORTED BY SCIENTIFIC AND BIOMEDICAL RESEARCH STUDIES

Download NRT Booklet for Physicians

Clinical Philosophy and Scientific Framework

Many vision-threatening eye diseases share overlapping pathophysiologic pathways that extend beyond localized ocular anatomy. Effective integrative eyecare looks at these systemic factors to support long-term ocular health.

These factors include:

  • Dysregulation of ocular and optic nerve microcirculation
  • Chronic low-grade inflammation and immune activation
  • Oxidative stress and mitochondrial dysfunction
  • Impaired neurotrophic signaling (including BDNF-related pathways)
  • Microvascular ischemia and endothelial dysfunction
  • Accelerated neurodegenerative processes

Netra Eye Institute's clinical focus is to modulate these upstream contributors using evidence-informed, non-invasive therapies that support physiologic resilience of retinal, optic nerve, and anterior segment tissues.

Our integrative eyecare are designed to be adjunctive to standard ophthalmic care, not replacements for surgical, pharmaceutical, or laser-based interventions when clinically indicated.

Netra Restoration Therapy (NRT): A Structured Integrative Model

Netra Restoration Therapy (NRT) is a protocol-driven therapeutic system developed to address ocular disease through multi-system regulation. As a cornerstone of our integrative eyecare approach, it incorporates:

Targeted Acupuncture Protocols

Acupuncture is applied using ophthalmology-specific point selection strategies derived from Traditional Chinese Medicine (TCM), Tung's Acupuncture, and neurovascular modulation principles.

The intent is to:

  • Improve ocular and retrobulbar blood flow
  • Support autonomic balance affecting ocular perfusion pressure
  • Modulate inflammatory cytokine activity
  • Enhance neurotrophic factor expression
  • Reduce oxidative and ischemic stress at the retinal and optic nerve level

Emerging biomedical literature has increasingly explored acupuncture's effects on cerebral and ocular circulation, neuroplasticity, and inflammatory signaling, which align with clinical observations in selected patients.

Ocular-Focused Herbal Pharmacology

When appropriate, customized herbal formulations are utilized to support systemic and ocular physiology.

These formulations are selected based on:

  • Microcirculatory support
  • Anti-oxidative and anti-inflammatory activity
  • Mitochondrial and metabolic support
  • Neuroprotective and vasoregulatory properties

Herbal components are chosen with careful attention to safety, quality control, and compatibility with patients' existing medical regimens.

Reducing Ferroptosis and Iron-Driven Cellular Damage

Ferroptosis is a form of programmed cell death driven by iron accumulation and lipid peroxidation. The retina is particularly vulnerable due to its high metabolic rate and rich lipid content.

Netra Restoration Therapy targets this pathway by:

  • Supporting iron homeostasis at the cellular level
  • Reducing lipid peroxidation stress
  • Enhancing antioxidant defense systems that protect retinal membranes

By addressing ferroptosis, NRT helps safeguard retinal cells from a less visible but highly destructive form of degeneration.

Traditional Ophthalmic Procedures

Select traditional ophthalmic procedures are incorporated as adjunctive modalities in carefully screened patients, primarily to support ocular surface health, periocular circulation, and neurosensory regulation. These interventions are applied within defined clinical indications and are not used as substitutes for standard ophthalmic treatments.

Key objectives include:

  • Ocular surface stabilization
    Support of tear film integrity, meibomian gland function, and epithelial resilience in patients with chronic dry eye disease, evaporative dysfunction, or inflammatory ocular surface conditions.
  • Periocular microcirculatory enhancement
    Gentle external therapies aimed at improving periocular blood flow and lymphatic drainage, potentially contributing to improved metabolic support of anterior segment structures.
  • Neurosensory modulation and fatigue reduction
    Interventions designed to reduce periocular neuromuscular tension and sensory overload, particularly in patients with asthenopia, chronic eye strain, or post-inflammatory hypersensitivity.
  • Adjunctive anti-inflammatory support
    Techniques selected to help modulate chronic low-grade periocular and ocular surface inflammation in appropriate clinical contexts.
  • Patient comfort and adherence optimization
    Supportive therapies that may improve patient comfort and tolerance of comprehensive treatment plans, thereby enhancing overall adherence to ongoing ophthalmic care.

All traditional ophthalmic procedures are performed conservatively, tailored to individual patient presentation, and integrated within a broader co-management framework with referring physicians.

Conditions Commonly Referred

Referring clinicians often consider Netra Eye Institute for patients with:

  • Primary open-angle and normal-tension glaucoma
  • Progressive optic neuropathy
  • Dry and wet age-related macular degeneration
  • Diabetic retinopathy and diabetic macular edema
  • Retinal vascular occlusive disease
  • Retinitis pigmentosa and inherited retinal dystrophies
  • Chronic uveitis and inflammatory eye disease
  • Keratoconus and corneal degenerations
  • Severe or refractory dry eye syndromes
  • Progressive visual field loss of unclear etiology

Patients are typically referred after diagnosis and baseline management have been established, particularly when disease progression continues despite guideline-based care.

Integration With Conventional Ophthalmology

Netra Eye Institute strongly encourages patients to remain under the ongoing care of their primary eye care provider. We view our role as complementary, focusing on physiologic support rather than replacing disease-specific interventions.

We recommend continued monitoring with standard diagnostic tools, including:

  • Optical coherence tomography (OCT) & OCT-A
  • Visual field testing
  • Intraocular pressure monitoring
  • Fundus photography
  • Corneal Topography
  • Electroretinography (ERG)

When appropriate, we collaborate with referring physicians to align therapeutic goals and ensure continuity of care.

Referral Process and Physician Communication

How Referrals Are Managed

Upon referral, our clinical team performs:

  • A comprehensive review of the patient's ophthalmic and systemic history
  • Evaluation of imaging, diagnostic tests, and prior treatment response
  • Determination of clinical suitability for integrative therapy
  • Development of a patient-specific therapeutic plan

Ongoing Communication with Referred Physicians

Referring clinicians may receive:

  • Initial case assessment summaries
  • Periodic treatment updates
  • Observational findings related to functional or symptomatic changes
  • Recommendations for continued co-management

We prioritize clear, professional communication to support informed clinical decision-making.

Patient Selection Considerations

Patients most likely to benefit from integrative care often share the following characteristics:

  • Chronic or progressive disease course
  • Stable systemic health permitting adjunctive therapy
  • Willingness to engage in a structured treatment plan
  • Continued compliance with conventional monitoring and care

As with all medical interventions, outcomes vary, and no therapy is presented as curative. Our focus is on supporting and improving ocular health, slowing progression, and optimizing functional potential where possible.

Contraindications and Exclusion Criteria

Traditional ophthalmic procedures are not universally appropriate and are offered only after careful clinical screening. The following contraindications and exclusion criteria are observed to ensure patient safety and appropriate integration with conventional ophthalmic care.

Absolute contraindications include:

  • Active ocular infection
    Including but not limited to bacterial, viral, or fungal keratitis, conjunctivitis, or endophthalmitis.
  • Recent intraocular surgery or trauma
    Patients within the acute postoperative or post-traumatic healing period, unless explicitly cleared by the treating ophthalmologist.
  • Uncontrolled ocular inflammation
    Such as active scleritis, severe uveitis, or acute inflammatory flares requiring systemic immunosuppression.
  • Open globe injury or corneal epithelial defect
    Including non-healed corneal ulcers, persistent epithelial defects, or neurotrophic keratopathy in the acute phase.

Relative contraindications and clinical caution are applied in patients with:

  • Advanced corneal compromise
    Including severe corneal thinning, ectasia at high risk for progression, or advanced neurotrophic keratitis.
  • Significant ocular surface instability
    Where external therapies may exacerbate epithelial fragility or inflammation.
  • Immunocompromised status
    Including patients receiving systemic chemotherapy, biologic immunosuppressants, or high-dose corticosteroids.
  • Unstable systemic medical conditions
    Such as poorly controlled diabetes mellitus or active systemic inflammatory disease impacting wound healing or infection risk.
  • Known hypersensitivity or intolerance
    To any materials, oils, or substances utilized during traditional ocular procedures.

Exclusion criteria include:

  • Patients seeking traditional ophthalmic procedures as a replacement for evidence-based ophthalmic care.
  • Patients unwilling to continue standard diagnostic monitoring or follow-up with their primary eye care provider.
  • Patients with expectations of curative outcomes inconsistent with the supportive, adjunctive role of these therapies.

All candidates undergo individualized assessment, and final determination of appropriateness is made within a multidisciplinary, patient-centered framework. Communication with the referring physician is encouraged when clinical uncertainty exists.

Physician Resources and Educational Collaboration

Netra Eye Institute provides access to:

  • Clinical overviews of integrative ophthalmic mechanisms
  • Case-based discussions and anonymized clinical observations
  • Educational materials for patients and clinicians
  • Direct physician-to-physician consultations

We welcome academic dialogue and multidisciplinary collaboration.

Related Articles

Keratoconus article
Keratoconus: An Inflammatory Disease in Disguise
Ocular blood flow article
Ocular Blood Flow and Vascular Dysregulation in Glaucoma
Glaucoma article
Glaucoma Beyond Eye Pressure: A Neurodegenerative Disease
ResourcesFor PhysiciansLocationsBlogFAQContact UsSearch
Request Consultation
Conditions We Treat
Netra Restoration Therapy
What is Netra Restoration TherapyBenefits of Netra Restoration TherapyNetra Restoration Therapy FAQNetra Restoration Therapy Effectiveness
Conditions We Treat
Retinal / Macular
ARMD - DryARMD - WetBest's DiseaseCentral Serous ChorioretinopathyCystoid Macular Edema (CME)Diabetic Macular Edema (DME)Diabetic RetinopathyMacular DystrophyMacular EdemaMacular HoleUsher SyndromeMacular TelangiectasiaMyopic DegenerationPattern DystrophyPolypoidal Choroidal VasculopathyRetinal Vein OcclusionRetinitis Pigmentosa (RP)RetinoschisisRod-Cone DystrophyStargardt Disease
Glaucoma
Normal Tension GlaucomaPrimary Open Angle Glaucoma
Optic Nerve / Neuro-ophthalmic
Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)Optic Nerve AtrophyOptic Neuritis
Corneal
Corneal DystrophyCorneal EctasiaCorneal NeuropathyCorneal NeuralgiaFuchs' DystrophyKeratoconusPost-LASIK Corneal Ectasia
Ocular Surface / Autoimmune
Dry EyesSjogren's SyndromePtosis
Refractive
AstigmatismFailed Lasik SurgeryMyopiaPresbyopia
Inflammatory
APMPPEChoroiditisKeratitisOptic NeuritisPanuveitisRetinal VasculitisUveitisWhite Dot Syndromes
Learn
Still Losing Vision?Why Vision Keeps Declining?Does Acupuncture Work?TCM & Ayurveda for Eye DiseaseInherited Retinal Disease
Patient Resources
Am I A CandidateTreatment FAQsTestimonialsPatient FeedbackFinancial AssistancePatient FinancingGalleryHSA, FSA and HRABlog
Treatment Systems
TCM OphthalmologyAyurveda OphthalmologyAcupuncture Ophthalmology
About
About Netra Eye InstituteMeet the TeamLocationsNews
\n